BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:148@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220301T140000 DTEND;TZID=Europe/Helsinki:20220301T150000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/immunology-seminar-heikki-hyoty/ SUMMARY:Immunology Seminar\, Heikki Hyöty DESCRIPTION: \;\n\n\n\nImmunology Seminar\n\nMarch 1st at 14:00 – 15: 00\nVirtual event\n\nHeikki Hyöty\, Tampere University\nType 1 Diabetes\, Enterovirus and Prospects of Vaccine Development\n\nHost: Riitta Lahesmaa (rilahes@utu.fi)\n\nRegistration latest Feb 28 at: https://link.webropols urveys.com/S/64C9EC43374D8B69\nZoom link and iCalendar invitation to join the online event will be sent to all registered participants one day befor e the event.\n\nImmunology seminar series is jointly organised by the Finn ish Society for Immunology\, InFLAMES Flagship and Turku Bioscience. For f urther information contact Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahe smaa (rilahes@utu.fi)\, University of Turku.\n\n \;\n\nDr. Heikki Hyö ty is Professor of Virology at Tampere University\, Faculty of Medicine an d Health Technology since 2013. Prof. Hyöty has received his PhD in virol ogy in 1989. He has served as Professor of Biomedicine and Virology at Uni versity of Tampere prior to his current position. Prof. Hyöty leads a vir ology group that studies the role of viruses and other microbes in immune- mediated diseases including type 1 diabetes\, asthma\, allergy and celiac disease. The group has studied  microbe-disease associations in prospecti ve cohorts and translated innovations to develop new treatments and better diagnostics. One major initiative is the project developing an enteroviru s vaccine that could prevent severe enterovirus diseases and type 1 diabet es. This project has generated a vaccine against Coxsackie B viruses which have been linked to type 1 diabetes.\n\nProfessor Hyöty is coordinator o f four EU funded projects\, and has 422 original articles and altogether n ine patents/patent applications.\n\nSelected publications:\n\n Sioofy-Kho jine AB\, Lehtonen J\, Nurminen N\, Laitinen OH\, Oikarinen S\, Huhtala H\ ,  Pakkanen O\, Ruokoranta T\, Hankaniemi MM\, Toppari J\, Vähä-Mäkil ä M\, Ilonen J\, Veijola R\, Knip M\, Hyöty H. Coxsackievirus B infectio ns are associated with the initiation of insulin-driven autoimmunity that progress to type 1 diabetes. Diabetologia 6:1193-1202\, 2018.\n Hyöty H\ , Leon F\, Knip M. Developing a vaccine for Type 1 diabetes by targeting c oxsackievirus B. Expert Rev Vaccines. 17(12):1071-1083\, 2018.\n Vehik K\ , Lynch KF\, Wong MC\, Tian X\, Ross MC\, Gibbs RA\, Ajami NJ\, Petrosino JF\,  Rewers M\, Toppari J\, Ziegler AG\, She JX\, Lernmark A\, Akolkar B \, Hagopian WA\, Schatz DA\, Krischer JP\, Hyöty H\, Lloyd RE\, and the T EDDY Study Group. Prospective virome analyses reveals prolonged enteroviru s B shedding precedes islet autoimmunity in children at increased genetic risk for type 1 diabetes. Nat Med. 25(12):1865-1872\, 2019.\n Stone VM\, Butrym M\, Hankaniemi MM\, Sioofy-Khojine A-B\, Hytönen VP\, Hyöty H\, F lodström-Tullberg M. Coxsackievirus B vaccines prevent infection-accelera ted diabetes in NOD mice and have no disease-inducing effect. Diabetes 70( 12):2871-2878\, 2021.\n Oikarinen S\, Krogvold L\, Edwin B\, Buanes T\, K orsgren O\, Laiho JE\, Oikarinen M\, Ludvigsson J\, Skog O\, Anagandula M\ , Frisk G\, Hyöty H*\, Dahl-Jørgensen K*. Characterisation of enteroviru s RNA detected in the pancreas and other specimens of live patients with n ewly diagnosed type 1 diabetes in the DiViD study. Diabetologia 64(11):249 1-2501\, 2021.\n END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20211031T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD END:VTIMEZONE END:VCALENDAR